Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive    source : Ir.biolinerx.com    save search
BioLineRx Announces Positive Results from Pharmacoeconomic Study Positioning Motixafortide as Potential Standard of Care in Stem Cell Mobilization
Published: 2021-10-13 (Crawled : 13:00) - ir.biolinerx.com
BLRX | $0.6771 3.14% 0.05% 170K twitter stocktwits trandingview |
Health Technology
 | | O: 9.89% H: 6.57% C: -1.04%
positive results stem cell potential positive results
BioLineRx Announces Positive Top-Line Results from GENESIS Phase 3 Trial of Motixafortide in Stem-Cell Mobilization for Autologous Bone Marrow Transplantation in Multiple Myeloma Patients
Published: 2021-05-04 (Crawled : 11:00) - ir.biolinerx.com
BLRX | $0.6771 3.14% 0.05% 170K twitter stocktwits trandingview |
Health Technology
 | | O: 53.29% H: 29.65% C: -0.2%
bone positive results phase 3 trial topline
Gainers vs Losers
74% 26%

Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M twitter stocktwits trandingview |

AGBA | $2.5 100.0% 56.6% 200M twitter stocktwits trandingview |
Finance
MLEC | $2.47 76.43% 42.62% 78M twitter stocktwits trandingview |
n/a
NUWE | $0.334 29.96% 40.99% 2.5M twitter stocktwits trandingview |
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M twitter stocktwits trandingview |

ATGL | $2.86 46.25% 32.8% 180K twitter stocktwits trandingview |

ZAPP | $0.2175 47.16% 32.05% 16M twitter stocktwits trandingview |
n/a
ONFO | $0.6088 38.68% 27.74% 7.3M twitter stocktwits trandingview |
n/a
VIVK | $1.48 38.32% 27.7% 530K twitter stocktwits trandingview |
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.